Loss of PTEN is frequently observed in androgen-independent prostate cancer, resulting in the deregulation of metastatic events. SDF1α activation of CXCR4 induces signaling pathways that have been implicated in prostate metastasis and progression to an advanced disease. The pathways of CXCR4 and PTEN converge, leading to the promotion and regulation of tumorigenesis, respectively. However, loss of PTEN may permit CXCR4 to progress prostate cancer to an advanced disease. In the present study, we investigated the involvement of PTEN in CXCR4-mediated tumorigenesis. When screening advanced metastatic prostate cancer 
INTRODUCTION
The relative 5-year survival rate among prostate cancer survivors is nearly 100%, versus a 15-year relative survival rate of 76% (1) . Improved treatments and methods of detection have translated into prostate cancers being found earlier in their development, and being treated more effectively. Despite these advances, Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Copyright © 2010 American Association for Cancer Research were blocked in blocking buffer (1% donkey serum in 1X PBS) at 4°C for 1 hour, followed by an incubation overnight in CXCR4 antibody (1:100) in blocking buffer at 4°C or without antibody (control). Cells were washed once in 1X PBS, followed by incubation in fluorescein isothiocyanate (FITC) or Indocarbocyanine (Cy3) fluorophore-conjugated secondary antibodies (1:500; Jackson ImmunoResearch) in blocking buffer at 4°C for 45 minutes. Cells were washed, resuspended in 1X PBS and the surface expression of CXCR4 was analyzed by flow cytometry (Accuri C6). Results were quantified using GraphPad Prism 5 statistical software.
Transient Transfection
Transient transfections of pcDNA3-GFP or pcDNA3-GFP-PTEN were performed in PC3 cells using Lipofectamine2000 (Invitrogen), generating the cell lines PC3-GFP and PC3-PTEN, respectively. Briefly, cells
) were plated in 6-well dishes, transfected according to the manufacturer's instructions and incubated at 37 °C in 5% CO 2 for 8 hours, prior to the addition of RPMI/10% FBS overnight. The next day, cells were serum starved or harvested. Transfection efficiency was monitored by measuring the percent of fluorescent cells among 500 total cells using the Cellometer Vision Trio 5 Program (Nexcelom Biosciences).
Migration Assay
Cell migration assays were done using 8 μm pore transwell chambers (Costar). Briefly, cells were grown in starvation media for 24 hours prior to detachment with 1X citric saline. Cells were resuspended in RPMI media, and 2×10 4 cells/well were added to the upper transwell chamber. RPMI containing 100 ng/mL of SDF1α was added to the lower chamber, and cells were allowed to migrate towards SDF1α in the lower chamber for [4] [5] [6] hours at 37°C. Cells that remained in the upper chamber were removed with a cotton swab, fixed and stained with Hemacolor Solution 3 Kit (EMD). Migrated cells were counted using a Zeiss Axiovert 200M light microscope. Results were quantified using GraphPad Prism 5 statistical program.
Proliferation (Viability) Assay
Cell proliferation was assessed by a MTT dye conversion assay at 570 nm following manufacturer's instructions starved for 24 hours prior to treating with 100 ng/mL of SDF1α at 37 °C in 5% CO 2 . At each time point (24 and 48 hours), cell were incubated with 10 µL of MTT reagent for 2 hours at 37°C, followed by 100 µL of detergent reagent at 37 °C for 2 hours. Proliferation (viability) was measured at 570 nm using a microplate reader (BioTek Synergy HT). Results were quantified using GraphPad Prism 5 statistical program.
Short Interfering RNA Transfection
Transient transfection of PTEN specific siRNA (Cell Signaling) was performed on Du145 cells using Lipofectamine2000. Briefly, cells ( 5×10 5 ) were plated in 100mm dishes and transfected with 100 µM PTENsiRNA or scramble-siRNA (Santa Cruz) in starvation media at 37 °C in 5% CO 2 for 24 hours. Transfected cells were harvested for western blot analysis or a migration assay.
Immunocytochemistry
Cells (3×10 4 ) were plated on glass slips in each well of a 10mm plate. Cells were washed with 1X PBS, fixed with 4% paraformaldehyde, washed twice for 5 minutes in Tris-glycine (0.1M glycine, pH 7.4), followed by a wash in 1X PBS. Non-specific binding sites were blocked in blocking buffer (5% normal donkey serum, 1%
BSA, 0.1% Tween20 in PBS) for 30 minutes, followed by incubation overnight with CXCR4 antibody (1:100) in blocking buffer at 4°C. Cells were washed thrice in 1X PBS, followed by an incubation in Cy3-conjugated secondary antibody (1:500) in blocking buffer for 45 minutes in the dark at room temperature. Cells were washed thrice in 1X PBS, followed by an incubation in 4',6-diamidino-2-phenylindole (DAPI, Sigma, 1:500 in PBS) for 1 minute. Glass coverslips were washed in 1X PBS prior to mounting on microscope slides with AquaPolymount (PolySciences, Inc). Fluorescence was analyzed by using a Zeiss Axio Imagwe.z1 fluorescence microscope. . Cells were sonicated and filtered through Whatman DE81 filter paper discs using a vacuum pump, prior to measuring the filter discs for radioactivity incorporation using a LS6500 multi-purpose scintillation counter (Backman Coulter, Brea, CA). Results were quantified using GraphPad Prism 5 statistical program.
Statistics and Quantifications
Data are presented as the mean ± SE of at least three independent experiments. The data was analyzed for twoway ANOVA or Student t-test. All statistical analyses were done, and all graphs generated, using GraphPad Prism 5.0 software (GraphPad).
RESULTS
PTEN was differentially expressed, while reconstitution of PTEN induced morphological changes in prostate cancer cells.
Based on the reports that PTEN haplosufficiency is strongly correlated with the conversion of prostate tumors to an invasive adenocarcinoma (3, 7) , and the observations that CXCR4 is highly expressed in advanced prostate tissues (17, 30) , we surmised that the absence of PTEN permits CXCR4-mediated functions and epithelioid morphotype, compared to fibroblastic-like cells transfected with PTEN mutants (34) . To further investigate this morphological transition, we analyzed the expression pattern of vimentin, an EMT marker (Fig.   2D ). We found that vimentin expression decreased in PC3-PTEN cells, compared to PC3-GFP cells. Copy DNA constructs were labeled with GFP; therefore, we utilized fluorescence microscopy to confirm that PTEN was expressed in these epithelial-like cells. We detected GFP-PTEN fusion protein at the cell membrane of PC3-PTEN cells, where it primarily functions (Fig. 2B) . To ensure that cDNA constructs were expressing the fusion protein, we detected PTEN expression by western blot analysis (Fig. 2C ).
PTEN expression inhibited CXCR-mediated migration and proliferation of prostate cancer cells
Prostate cancer tends to spread to the bones. The CXCR4/SDF1α signaling axis was shown to play a pivotal role in triggering prostate bone metastasis (19), while Wu et al observed that PTEN inhibited C42 cell migration toward calvaria-conditioned medium (24) . To examine whether PTEN negatively regulates CXCR4-mediated migration and proliferation, respective assays were performed with PC3, PC3-GFP or PC3-PTEN cells upon CXCR4 stimulation with its ligand, SDF1α. By transwell assay, we observed an increase in cell migration of PC3 and PC3-GFP cells towards SDF1α in the bottom chamber (Fig. 3A) . However, SDF1α failed to stimulate movement of PC3-PTEN cells (Fig. 3A) , resulting in a significant reduction in cell migration compared to PC3 and PC3-GFP cells (Fig. 3B ).
To (Fig. 4A) . Phospho-ERK1/2 levels did not change (Fig. 4A) . Treatment of serum starved PC3-GFP and PC3-PTEN cells with SDF1α resulted in ERK1/2 phosphorylation in a biphasic manner, while no changes in AKT phosphorylation were observed compared to control (Fig. 4B ). Phospho-ERK1/2 was detected in PC3-GFP cells upon SDF1α stimulation, but not in PC3-PTEN cells under the same conditions (Fig.   4B ).
To determine whether PTEN-mediated inhibition of ERK1/2 phosphorylation was responsible for the decreased CXCR4-mediated cell migration of PC3-PTEN cells, we used PD98059, a small molecule MEK inhibitor to suppress ERK1/2 phosphorylation, and LY294002, a small molecule PI3K inhibitor to suppress AKT phosphorylation. Pretreatment with PD98059 for 1hour abrogated SDF1α-induced phosphorylation of ERK1/2, while LY294002 abrogated phosphorylation of AKT (Fig. 4C ). Since we observed that PTEN blocked SDF1α-induced phosphorylation of ERK1/2, we then determined whether ERK1/2 abrogation inhibited CXCR4-mediated migration of PC3 cells. We monitored transwell cell migration of PC3 and PC3-GFP cells towards SDF1α in the presence and absence of LY294002 and PD98059. Pretreatment with PD98059
significantly inhibited PC3 and PC3-GFP migration, which was not inhibited by LY294002 (Figs. 4D and 4F ).
PD98059, nor LY294002, was cytotoxic to the cells (data not shown). Western blot analysis (Fig. 5A ) and a significant increase in migratory activity towards SDF1α (Fig. 5B ).
Downregulation of PTEN expression enhanced CXCR4-mediated migration of Du145 cells
Migratory activity towards SDF1α was not observed in control transfected cells. These finding suggest that there is a reciprocal relationship between CXCR4 activity and PTEN expression. Taken together, these results support the idea that the loss of PTEN regulation permits the advancement of prostate cancer through CXCR4, and its concomitant pathways. (12, 18, 19) . Downstream, CXCR4-initiated signaling leads to the transcription of genes involved in migration and tumorigenesis (14) .
Traditionally, PTEN functions as a dual-specificity lipid and protein phosphatase that inhibits tumorigenic events through dephosphorylation of PIP3, thus antagonizing PI3K/AKT-mediated signaling (8) . By converting PIP3 into PIP2, PTEN negatively regulates PI3K/AKT signaling and subsequent downstream pathways. PTEN and CXCR4 converge at the PI3K/AKT and/or MAPK signaling level. This is supported by our research and others, that PI3K/AKT and/or ERK inhibitors mimicked PTEN's effect of negatively regulating CXCR4 (27) .
Therefore, our research describes that the loss of PTEN expression provides a "permissive switch" for CXCR4-mediated signaling and functions (Fig. 6 ). 
ACKNOWLEDGEMENTS
Limitations of space preclude extensive citation of literature; we apologize to those whose work is not mentioned herein. Research in this lab is supported, in part, by National Institutes of Health Grants
5R25GM060414 (MBRS-RISE)(MAC), 1P20MD002285 (P20)(VOM) and 2G12RR003062-22 (RCMI)(CVH).
We would like to thank Dr. Alonzo Ross (UMass, Worcester) for the pcDNA3-GFP and pcDNA3-GFP-PTEN constructs. We also thank Brittany T. Jones, Amber L. Taylor and T'Shane C. Williams (CAU) for technical support. Cells were probed with a CXCR4 (red) specific antibody. Nuclei were stained with DAPI (blue). (*, P < 0.05). ) were seeded into the upper chamber of transwell inserts and allowed to migrate towards 100ng/mL of SDF1α for 6 h at 37˚C. Five fields were randomly selected and counted for migrated cells at 10X magnification. Experiments were repeated thrice and data represents the averages of three independent experiments. (*, P < 0.05). 
FIGURE LEGENDS

